Effect of aspirin and ifetroban on skeletal muscle blood flow in patients with congestive heart failure treated with enalapril
Open Access
- 31 July 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 34 (1) , 170-176
- https://doi.org/10.1016/s0735-1097(99)00180-1
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Is aspirin safe for patients with heart failure?Heart, 1995
- Comparing Angiotensin-Converting Enzyme Inhibitor Trial Results in Patients With Acute Myocardial InfarctionArchives of internal medicine (1960), 1994
- Role of shear stress and endothelial prostaglandins in flow- and viscosity-induced dilation of arterioles in vitro.Circulation Research, 1993
- Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failureJournal of the American College of Cardiology, 1992
- Why are converting enzyme inhibitors vasodilators?British Journal of Clinical Pharmacology, 1989
- Dependence of enhanced maximal exercise performance on increased peak skeletal muscle perfusion during long-term captopril therapy in heart failureJournal of the American College of Cardiology, 1987
- Lack of relationship between the short-term hemodynamic effects of captopril and subsequent clinical responses.Circulation, 1984
- Differential Inhibition by Aspirin of Vascular and Platelet Prostaglandin Synthesis in Atherosclerotic PatientsNew England Journal of Medicine, 1983
- Comparison of Blood Flow Measured by Plethysmograph and Flowmeter During Steady State Forearm ExerciseCirculation, 1974
- METHODS FOR THE INVESTIGATION OF PERIPHERAL BLOOD FLOWBritish Medical Bulletin, 1963